Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
guardian 1: Safety and Efficacy of N8 in Haemophilia A
NCT00840086Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2009
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 18
01
Overview
A Phase 3 trial of turoctocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Apr 2009; status: completed.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00840086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840086.